Rheumatology NewsWhy not both? Dual biologics for treatment-resistant RA and PsAJune 12, 2023Rheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsIs ChatGPT a friend or foe of medical publishing?June 9, 2023Business of MedicineRheumatoid Arthritis
Rheumatology NewsStudies reveal nuances in efficacy, MACE risk between JAKi and TNFiJune 7, 2023Rheumatoid Arthritis
Rheumatology NewsILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDsJune 1, 2023Psoriatic ArthritisRheumatoid Arthritis
Rheumatology NewsFDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsFDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPediatricsPsoriatic Arthritis
Worse outcomes among elderly patients with RA undergoing percutaneous coronary interventionMay 18, 2023Rheumatoid Arthritis
Comparable efficacy of TNFi and IL-6Ri in b/tsDMARD-experienced patients with RAMay 18, 2023Rheumatoid Arthritis
Mendelian randomization study supports causal association between RA and coronary atherosclerosisMay 18, 2023Rheumatoid Arthritis
No evidence to indicate significantly higher risk for cancer with JAKi vs bDMARD in RAMay 18, 2023Rheumatoid Arthritis
HPV infection, HPV immunization, and RA prevalence: What is the link?May 18, 2023Rheumatoid Arthritis
Factors guiding sustained remission after withdrawal of combination therapy in RAMay 18, 2023Rheumatoid Arthritis
Tofacitinib withdrawal not a universal option for all patients with RA in remissionMay 18, 2023Rheumatoid Arthritis
